Henshaw Capital’s Ligand Pharmaceuticals LGND Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-4,668
| Closed | -$827K | – | 219 |
|
|
2025
Q3 | $827K | Sell |
4,668
-1,728
| -27% | -$257K | 0.03% | 125 |
|
|
2025
Q2 | $727K | Hold |
6,396
| – | – | 0.03% | 185 |
|
|
2025
Q1 | $672K | Hold |
6,396
| – | – | 0.03% | 188 |
|
|
2024
Q4 | $685K | Hold |
6,396
| – | – | 0.03% | 167 |
|
|
2024
Q3 | $640K | Hold |
6,396
| – | – | 0.03% | 184 |
|
|
2024
Q2 | $539K | Buy |
6,396
+102
| +2% | +$8.12K | 0.02% | 166 |
|
|
2024
Q1 | $460K | Hold |
6,294
| – | – | 0.02% | 185 |
|
|
2023
Q4 | $450K | Hold |
6,294
| – | – | 0.02% | 191 |
|
|
2023
Q3 | $377K | Buy |
6,294
+2,747
| +77% | +$181K | 0.02% | 188 |
|
|
2023
Q2 | $256K | Buy |
3,547
+321
| +10% | +$24.1K | 0.01% | 205 |
|
|
2023
Q1 | $237K | Hold |
3,226
| – | – | 0.01% | 211 |
|
|
2022
Q4 | $215K | Sell |
3,226
-1,945
| -38% | -$126K | 0.01% | 223 |
|
|
2022
Q3 | $278K | Hold |
5,171
| – | – | 0.02% | 214 |
|
|
2022
Q2 | $288K | Hold |
5,171
| – | – | 0.02% | 229 |
|
|
2022
Q1 | $363K | Buy |
5,171
+838
| +19% | +$60.8K | 0.02% | 211 |
|
|
2021
Q4 | $418K | Hold |
4,333
| – | – | 0.02% | 196 |
|
|
2021
Q3 | $377K | Hold |
4,333
| – | – | 0.02% | 206 |
|
|
2021
Q2 | $355K | Hold |
4,333
| – | – | 0.02% | 242 |
|
|
2021
Q1 | $412K | Sell |
4,333
-835
| -16% | -$78.9K | 0.03% | 199 |
|
|
2020
Q4 | $321K | Hold |
5,168
| – | – | 0.02% | 242 |
|
|
2020
Q3 | $307K | Hold |
5,168
| – | – | 0.02% | 216 |
|
|
2020
Q2 | $361K | Buy |
5,168
+524
| +11% | +$33.2K | 0.03% | 185 |
|
|
2020
Q1 | $211K | Buy |
+4,644
| New | +$263K | 0.02% | 250 |
|
|
2019
Q2 | – | Sell |
-2,754
| Closed | -$216K | – | 299 |
|
|
2019
Q1 | $216K | Buy |
+2,754
| New | +$209K | 0.02% | 258 |
|
Other funds holding LGND
NAMI
CC
SIMG